Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Recap by typeshit. Post by Facebook on Facebook.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
He says close to 40% of weight lost in the trial's body-scan group was lean mass, and argues muscle loss isn't the drug's fault.
Women on CagriSema hit 20% weight loss far more often than on semaglutide alone, 68.7% vs 38.0%, though Novo calls the comparisons exploratory.
The Sugarfit co-founder and the doctor argue that managing weight on GLP-1 medications takes more than the drug by itself.
Loading…